IGC Pharma
25 hedge funds and large institutions have $817K invested in IGC Pharma in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
-5
Holders Change %
-16.67%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$26.1K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$9.14K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.65K |
| 4 |
Squarepoint
New York
|
+$4.15K |
| 5 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
+$1.74K |
Top Sellers
| 1 |
TSS
Two Sigma Securities
New York
|
-$20.5K |
| 2 |
HF
HRT Financial
New York
|
-$9K |
| 3 |
DP
Dearborn Partners
Chicago,
Illinois
|
-$7.13K |
| 4 |
Jane Street
New York
|
-$5.63K |
| 5 |
VF
Virtu Financial
New York
|
-$4K |
